Next Generation Nebuliser Drug Delivery Technology
ActiveRegistered as Acu-Flow Limited
Data to 4 Nov 2026, 00:57
- Company number
- SC624449
- Sector
- Health and life sciences
- SIC group
- Life sciences and health
- Region
- Scotland (Glasgow)
- Incorporated
- 14 Mar 2019
- SIC codes
- 32500, 74909
- Trading name
- Next Generation Nebuliser Drug Delivery Technology
- Website
- nebuflow.com Company number on the site, checked 16 Oct 2026
Next Generation Nebuliser Drug Delivery Technology has 3 priced rounds on record from share allotment filings at Companies House. The latest was allotted on 1 Nov 2024, raised £750k, and was filed on 5 Nov 2024. Data to 3 Nov 2026.
3
Priced rounds
Allotted Apr 2022 to Nov 2024
£6.46m
Cash raised in those rounds
Sum of sterling cash raised in each round, as filed
1 Nov 2024
Latest round allotted
Filed 5 Nov 2024
Jump to
Funding rounds
Priced equity rounds read from share allotment filings at Companies House, newest first.
| Allotted | First filed | Cash raised | Filing |
|---|---|---|---|
| 1 Nov 2024Latest | 5 Nov 2024 | £750k | Open filing |
| 4 Apr 2024 | 9 Apr 2024 | £3.96m | Open filing |
| 5 Apr 2022 | 8 Apr 2022 | £1.76m | Open filing |
Companies with significant control
Companies with significant control over Next Generation Nebuliser Drug Delivery Technology, from the register of people with significant control. A company can have control without holding shares. Individuals are not shown on public pages.
| Holder | Notified | Ceased | Shares held |
|---|---|---|---|
| Gu Holdings Limited | 14 Mar 2019 | 5 Apr 2022 | 25 to 50% |
From the PSC register.
Filings
The latest 6 capital filings other than share allotments (SH01), which are listed under Funding rounds. 4 share filings (SH01) have been read for this company.
| Date | Filing | Document |
|---|---|---|
| 9 Apr 2024 | Resolution | Open at Companies House |
| 9 Apr 2024 | Memorandum and articles (MA) | Open at Companies House |
| 8 Apr 2022 | Resolution | Open at Companies House |
| 8 Apr 2022 | Memorandum and articles (MA) | Open at Companies House |
| 10 Feb 2022 | Resolution | Open at Companies House |
| 10 Feb 2022 | Memorandum and articles (MA) | Open at Companies House |
Documents open at Companies House. Bradshaw does not store or re-host them.
About this page
This page shows public register data for Next Generation Nebuliser Drug Delivery Technology. Figures come from filings at Companies House; Bradshaw links to each filing and does not host copies. To correct or object to data about you, use the data request form.
Last updated 3 Nov 2026